Revolutionizing

Healthcare Through Better Insight

Better treatment starts with more timely and more precise detection, at the very beginning.

As a fast-growing biotechnology company dedicated to inspiring a new state of health, we are committed to providing patients and healthcare providers with the innovative diagnostic and data tools needed to make better health decisions.

Our science-first approach to innovation ensures that our products are among the most effective, fast and affordable. Our INDICAID COVID-19 Rapid Antigen tests are EUA and available for both point-of-care and over the counter use.

Our proprietary technology, PHASIFY, redefines the gold standard of diagnostics by making target molecules quicker and easier to detect. The power of PHASIFY is being utilized in current product development as we continue to pioneer new diagnostics for other infectious diseases and cancer.